Xoma reported $-5894000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US USD 7.41B 84M
Agenus AGEN:US USD -74102000 17.39M
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
Ardelyx ARDX:US USD 10.7M 33.59M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Bluebird Bio BLUE:US USD -76513000 16.99M
Celldex Therapeutics CLDX:US USD -26487000 297K
Chimerix CMRX:US USD -21077000 262.59M
Curis CRIS:US USD -11329000 1.96M
Eli Lilly And LLY:US USD 2.04B 38.3M
Emergent Biosolutions EBS:US USD 6.6M 54.9M
Intercept Pharmaceuticals ICPT:US USD -17543000 86.54M
Life Technologies LIFE:US USD -7523000 5.72M
Macrogenics MGNX:US USD 12.8M 37.61M
Novartis NOVN:VX USD 3.86B 195M
Novartis NVS:US USD 3.86B 195M
Pfizer PFE:US USD 7.38B 3.3B
Prothena PRTA:US USD 3.34M 51.76M
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Xoma XOMA:US USD -5894000 1.72M
YTE INCY:US USD 178.62M 401K